Similar articles for PMID: 34857621

Year	Number of Results
1997	1
1998	3
1999	2
2000	1
2001	2
2003	3
2004	3
2005	4
2006	1
2007	1
2008	4
2009	1
2010	2
2011	3
2012	3
2013	6
2014	9
2015	15
2016	7
2017	5
2018	7
2019	8
2020	8
2021	18
2022	11
2023	1

1

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources.

Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. Capala J, et al. J Nucl Med. 2021 Dec;62(Suppl 3):3S-11S. doi: 10.2967/jnumed.121.262749. J Nucl Med. 2021. PMID: 34857621 Free article.

2

Technical note: A wearable radiation measurement system for collection of patient-specific time-activity data in radiopharmaceutical therapy: system design and Monte Carlo simulation results.

Morganti S, Collamati F, Faccini R, Iaccarino G, Mancini-Terracciano C, Mirabelli R, Nicolanti F, Pacilio M, Soriani A, Solfaroli-Camillocci E. Morganti S, et al. Med Phys. 2021 Dec;48(12):8117-8126. doi: 10.1002/mp.15311. Epub 2021 Nov 23. Med Phys. 2021. PMID: 34704618 Free PMC article.

3

Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.

Grimes J, Celler A, Birkenfeld B, Shcherbinin S, Listewnik MH, Piwowarska-Bilska H, Mikolajczak R, Zorga P. Grimes J, et al. J Nucl Med. 2011 Sep;52(9):1474-81. doi: 10.2967/jnumed.111.088203. Epub 2011 Jul 27. J Nucl Med. 2011. PMID: 21795364 Free article.

4

DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches.

Pérez P, Valente M. Pérez P, et al. Appl Radiat Isot. 2019 Aug;150:135-140. doi: 10.1016/j.apradiso.2019.05.031. Epub 2019 May 24. Appl Radiat Isot. 2019. PMID: 31146217

5

Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.

Padilla L, Lee C, Milner R, Shahlaee A, Bolch WE. Padilla L, et al. J Nucl Med. 2008 Mar;49(3):446-52. doi: 10.2967/jnumed.107.046722. Epub 2008 Feb 20. J Nucl Med. 2008. PMID: 18287264 Free article.

6

Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.

Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M. Herrmann K, et al. J Nucl Med. 2015 Mar;56(3):410-6. doi: 10.2967/jnumed.114.151647. Epub 2015 Feb 19. J Nucl Med. 2015. PMID: 25698782 Free article.

7

Modern Radiopharmaceutical Dosimetry Should Include Robust Biodistribution Reporting.

Kesner AL, Bodei L. Kesner AL, et al. J Nucl Med. 2018 Oct;59(10):1507-1509. doi: 10.2967/jnumed.118.208603. Epub 2018 Mar 30. J Nucl Med. 2018. PMID: 29602815 Free article.

8

Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.

Wallhaus TR, Lacy J, Whang J, Green MA, Nickles RJ, Stone CK. Wallhaus TR, et al. J Nucl Med. 1998 Nov;39(11):1958-64. J Nucl Med. 1998. PMID: 9829589 Free article. Clinical Trial.

9

Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.

Beauregard JM. Beauregard JM. Cancer Imaging. 2022 Dec 9;22(1):67. doi: 10.1186/s40644-022-00505-y. Cancer Imaging. 2022. PMID: 36494731 Free PMC article. Review.

10

Dosimetry in Radiopharmaceutical Therapy.

O'Donoghue J, Zanzonico P, Humm J, Kesner A. O'Donoghue J, et al. J Nucl Med. 2022 Oct;63(10):1467-1474. doi: 10.2967/jnumed.121.262305. J Nucl Med. 2022. PMID: 36192334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed